Peer-Reviewed Publications

CPCE investigators are international experts in their clinical effectiveness-related fields, and have authored hundreds of pediatric research articles in leading peer-reviewed journals. From here you can access CPCE journal article abstracts by author, title, or year.

Found 1465 results
Author [ Title(Desc)] Year
Filters: First Letter Of Last Name is L  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
R
J Donnelly P, Chen SC, Kauffman CA, et al. "Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium." Clin. Infect. Dis.. 2019.
Rattanaumpawan P, Nachamkin I, Bilker WB, et al. "Risk factors for ambulatory urinary tract infections caused by high-MIC fluoroquinolone-susceptible Escherichia coli in women: results from a large case-control study." J. Antimicrob. Chemother.. 2015;70(5):1547-51.
Han JH, Nachamkin I, Zaoutis TE, et al. "Risk factors for gastrointestinal tract colonization with extended-spectrum β-lactamase (ESBL)-producing Escherichia coli and Klebsiella species in hospitalized patients." Infect Control Hosp Epidemiol. 2012;33(12):1242-5.
Han JH, Nachamkin I, Zaoutis TE, et al. "Risk factors for gastrointestinal tract colonization with extended-spectrum β-lactamase (ESBL)-producing Escherichia coli and Klebsiella species in hospitalized patients." Infect Control Hosp Epidemiol. 2012;33(12):1242-5.
Fisher BT, Robinson PD, Lehrnbecher T, et al. "Risk Factors for Invasive Fungal Disease in Pediatric Cancer and Hematopoietic Stem Cell Transplantation: A Systematic Review." J Pediatric Infect Dis Soc. 2017.
Cluzet VC, Gerber JS, Nachamkin I, et al. "Risk factors for recurrent colonization with methicillin-resistant Staphylococcus aureus in community-dwelling adults and children." Infect Control Hosp Epidemiol. 2015;36(7):786-93.
Cluzet VC, Gerber JS, Nachamkin I, et al. "Risk factors for recurrent colonization with methicillin-resistant Staphylococcus aureus in community-dwelling adults and children." Infect Control Hosp Epidemiol. 2015;36(7):786-93.
Fisher BT, Zaoutis TE, Leckerman KH, Localio R, Aplenc R. "Risk factors for renal failure in pediatric patients with acute myeloid leukemia: a retrospective cohort study." Pediatr Blood Cancer. 2010;55(4):655-61.
Fisher BT, Zaoutis TE, Leckerman KH, Localio R, Aplenc R. "Risk factors for renal failure in pediatric patients with acute myeloid leukemia: a retrospective cohort study." Pediatr Blood Cancer. 2010;55(4):655-61.
Ndiaye M, Nyasulu P, Nguyen H, et al. "Risk factors for suboptimal antiretroviral therapy adherence in HIV-infected adolescents in Gaborone, Botswana: a pilot cross-sectional study." Patient Prefer Adherence. 2013;7:891-5.
Kotch C, Avery R, Getz KD, et al. "Risk Factors for Treatment Refractory and Relapsed Optic Pathway Glioma in Children with Neurofibromatosis Type 1." Neuro Oncol. 2022.
Kotch C, Avery R, Getz KD, et al. "Risk Factors for Treatment Refractory and Relapsed Optic Pathway Glioma in Children with Neurofibromatosis Type 1." Neuro Oncol. 2022.
Kotch C, Avery R, Getz KD, et al. "Risk Factors for Treatment Refractory and Relapsed Optic Pathway Glioma in Children with Neurofibromatosis Type 1." Neuro Oncol. 2022.
Vajravelu RK, Copelovitch L, Osterman MT, et al. "Risk for Chronic Kidney Disease in Patients with Inflammatory Bowel Diseases Increases with Age but is not Associated with 5-aminosalicylate Use." Clin. Gastroenterol. Hepatol.. 2019.
Rubin DM, Kreider AR, Matone M, et al. "Risk for incident diabetes mellitus following initiation of second-generation antipsychotics among Medicaid-enrolled youths." JAMA Pediatr. 2015;169(4):e150285.
Elgarten CW, Otto WR, Shenton L, et al. "Risk of bacterial bloodstream infection does not vary by central-line type during neutropenic periods in pediatric acute myeloid leukemia." Infect Control Hosp Epidemiol. 2022:1-8.
Egbe TI, Montoya-Williams D, Wallis K, Passarella M, Lorch SA. "Risk of Extreme, Moderate and Late Preterm Birth by Maternal Race, Ethnicity and Nativity." J Pediatr. 2021.
Denburg MR, Leonard MB, Haynes K, et al. "Risk of fracture in urolithiasis: a population-based cohort study using the health improvement network." Clin J Am Soc Nephrol. 2014;9(12):2133-40.
Feemster KA, Li Y, Localio AR, et al. "Risk of invasive pneumococcal disease varies by neighbourhood characteristics: implications for prevention policies." Epidemiol. Infect.. 2013;141(8):1679-89.
Feemster KA, Li Y, Localio AR, et al. "Risk of invasive pneumococcal disease varies by neighbourhood characteristics: implications for prevention policies." Epidemiol. Infect.. 2013;141(8):1679-89.
Feemster KA, Li Y, Localio AR, et al. "Risk of invasive pneumococcal disease varies by neighbourhood characteristics: implications for prevention policies." Epidemiol. Infect.. 2013;141(8):1679-89.
Denburg MR, Leonard MB, Jemielita TO, Golden NH, Tasian GE, Copelovitch L. "Risk of Urolithiasis in Anorexia Nervosa: A Population-Based Cohort Study Using the Health Improvement Network." Eur Eat Disord Rev. 2017;25(5):406-410.
Aronson PL, Wang ME, Shapiro ED, et al. "Risk Stratification of Febrile Infants ≤60 Days Old Without Routine Lumbar Puncture." Pediatrics. 2018.
Kadauke S, Myers RM, Li Y, et al. "Risk-Adapted Preemptive Tocilizumab to Prevent Severe Cytokine Release Syndrome After CTL019 for Pediatric B-Cell Acute Lymphoblastic Leukemia: A Prospective Clinical Trial." J Clin Oncol. 2021:JCO2002477.
Kadauke S, Myers RM, Li Y, et al. "Risk-Adapted Preemptive Tocilizumab to Prevent Severe Cytokine Release Syndrome After CTL019 for Pediatric B-Cell Acute Lymphoblastic Leukemia: A Prospective Clinical Trial." J Clin Oncol. 2021:JCO2002477.

Pages